Sentry-SECURE is a new communication and response platform developed by PNNL, VPI, and Microsoft Azure that rapidly and securely transfers radiological alarm data through the cloud.
PNNL is piloting a novel web-based resilience planning tool for managing risk to mission-critical infrastructure from disruptions in energy and water services.
Night shift work disrupts the natural 24-hour rhythms in the activity of certain cancer-related genes, making workers more vulnerable to damage to their DNA.
PNNL-developed Water Balance Tool estimates consumption for major water end-uses. Understanding the breakout of water use identifies water efficiency opportunities and allows facility managers to spot potential system losses.
PNNL created an assessment method and maturity model that helps manufacturers building products for the power grid implement consistent cybersecurity best practices throughout their development lifecycle.
Ann Lesperance, national security advisor, joins the National Academies of Sciences, Engineering, and Medicine Committee on Applied Research Topics for Hazard Mitigation and Resilience.
In a first-of-its-kind study, PNNL scientists are learning about how e-cigarettes can lead to changes in proteins at the molecular level that could contribute to disease or other health problems.
Researchers at PNNL have developed a bacteria testing system called OmniScreen that combines biological and synthetic chemistry with machine learning to hunt down pathogens before they strike.
The Facility Cybersecurity toolkit, developed by PNNL, is designed for federal facilities to help implement the presidential executive order on cybersecurity, but it is also available for commercial facilities without charge.
The nation’s ability to test for COVID-19 has expanded, thanks to work at Pacific Northwest National Laboratory, where scientists have established the performance of testing equipment to detect the virus.
Researchers from PNNL have helped colleagues at OHSU identify lipid molecules required for Zika infection in human cells. The specific lipids involved could also be a clue to why the virus primarily infects brain tissue.
Biomedical scientist Brian Thrall co-edited the issue published in the journal NanoImpact. Three of the articles in the issue include multiple PNNL authors.